Imagion Biosystems Limited

IBXXFOTCHealthcare● Active

$0.03

+$0.00(+0.00%)

Market Cap$6626738

P/E Ratio—

52W High$0.04

52W Low$0.008

Avg Volume4K

Open$0.02

Beta-0.21

Cash on Hand Financials Revenue

Imagion Biosystems Limited (IBXXF) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

IBXXF · cash on hand · updated Dec 31, 2025

Core cash position

as of Dec 31, 2025

Cash & Short-Term Investments (CCE + ST Investments)

$1.8M▼ -30.8% vs prior year

FY · as of Dec 31, 2025 · Reported in AUD

Cash & Cash Equiv. (CCE)

$1.8M

cashAndCashEquivalents

Short-Term Investments

shortTermInvestments

YoY Change vs Prior Year

-30.8%

vs prior fiscal year

Latest Quarter

$1.8M

Q4 2025

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in AUD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$1.8MCash on Hand

Total Debt$2.6MTotal Debt

Net Cash / Net Debt−$716,441Net Debt Position

Cash vs Debt Ratio

Cash 42%Imagion Biosystems Limited cash as % of market cap: 27.87%% · MCap $0BDebt 58%

Imagion Biosystems Limited carries a net debt position of $716,441. Total debt ($2.6M) exceeds cash on hand ($1.8M). Imagion Biosystems Limited cash vs debt ratio: 42% cash / 58% debt.

Net Cash = Cash & ST Investments − Total Debt$1.8M − $2.6M = −$716,441

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

IBXXF annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

IBXXF cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Dec 31, 2025LatestFY$1.8M-30.8%

Dec 31, 2024FY$2.7M+1076.0%

Dec 31, 2023FY$0.2M-94.9%

Dec 31, 2022FY$4.4M-66.8%

Dec 31, 2021FY$13.4M+1.5%

IBXXF cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

IBXXF vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

Imagion Biosystems LimitedYOU

IBXXF

$1.8M$7M27.9%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Imagion Biosystems Limited (IBXXF) cash on hand as of December 31, 2025 is $1.8M, comprising $1.8M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Imagion Biosystems Limited cash and short-term investments on the balance sheet (10-K filing). Also referred to as Imagion Biosystems Limited cash reserves or cash position.

Imagion Biosystems Limited annual cash on hand history shows decreased -30.8% in 2025: decreased -30.8% in 2025. Imagion Biosystems Limited cash reserves in 2025 reflect the company's capital allocation strategy.

Imagion Biosystems Limited carries total debt of $2.6M against cash of $1.8M, resulting in a net debt position of -$716,441. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

IBXXF cash on hand · 5 questions

As of December 31, 2025, Imagion Biosystems Limited (IBXXF) has $1,846,941 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $1,846,941 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (December 31, 2025): $1,846,941. Data sourced from the annual 10-K filing via FMP.

IBXXF cash on handIBXXF cash reservesIBXXF cash 2025how much cash does IBXXF have

▸ Source: FMP /balance-sheet-statement · US GAAP · Imagion Biosystems Limited · Imagion Biosystems Limited SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025